Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in children with refractory nephrotic syndrome
ChiCTR-ONC-10001125Phase 4Completed
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Jan 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rituximab in nephrosis, sponsored by General Hospital of Eastern Military Command. Primary endpoints: CD8, CD20 and 3 more. Started Jan 2011; status: completed.
02
Drugs
rituximab
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR-ONC-10001125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-10001125.